Article Type – Page 74 – Brazilian Journal of Pathology and Laboratory Medicine

Underreporting of scientific knowledge: a theme for reflection

Histopathological features of mucosa atrophy in atrophic body gastritis

Características histopatológicas da atrofia da mucosa na gastrite atrófica do corpo Alfredo J. A. Barbosa; Marcela S. Boldt; Carolinne B. Rodrigues; Camila S. C. Silva; Hulie M. Ferreira; Rivelle D. Pereira Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brasil DOI: 10.5935/1676-2444.20160006 Corresponding author Alfredo J. A. BarbosaInstituto Alfa de Gastroenterologia; Hospital das Clínicas da […]

Histopathological features of mucosa atrophy in atrophic body gastritis Read More »

Severe glandular atrophy of the gastric corpus. Presence of few remaining oxyntic glands presenting regressive changes (short arrows), and numerous mucous secreting glands, named PSA (long arrows). HE, original magnification 100× PSA: pseudoantral metaplasia; HE: hematoxylin and eosin.

Histopathological features of mucosa atrophy in atrophic body gastritis

Article Type, Issue, Pathology, Vol 52, Issue 1 / cadmin

Alfredo J. A. Barbosa; Marcela S. Boldt; Carolinne B. Rodrigues; Camila S. C. Silva; Hulie M. Ferreira; Rivelle D. PereiraJ. Bras. Patol. Med. Lab. 2016;52(1):50-54DOI: 10.5935/1676-2444.20160006 ABSTRACT INTRODUCTION: Gastric mucosa atrophy became a major issue in gastric pathology because of its connection with risk lesions for gastric cancer. Although gastric atrophy is frequently associated with different

Histopathological features of mucosa atrophy in atrophic body gastritis Read More »

Evaluation of TP53 Gene Expression in Patients with Childhood Cancer in Northeast Santa Catarina, Brazil

JBPML puts its commitment to the care of safety in the laboratory

Article Type, Editorial, Issue, Vol 51, Issue 6 / wadmin

Silvana Maria Eloi-SantosJ. Bras. Patol. Med. Lab. 2015;51(6):358DOI: 10.5935/1676-2444.20150056 ABSTRACT In 2009, the US Food and Drug Administration (FDA) approved the Clinical and Laboratory Standards Institute ([CLSI] – formerly NCCLS) consensus standard for auto verification of clinical laboratory test results(1). That guideline provides a general framework that allows clinical laboratories to propose, implement, validate, and

JBPML puts its commitment to the care of safety in the laboratory Read More »

JBPML puts its commitment to the care of safety in the laboratory

Editorial / wadmin

Silvana Maria Eloi-Santos Jornal Brasileiro de Patologia e Medicina Laboratorial (JBPML); Universidade Federal de Minas Gerais (UFMG) DOI: 10.5935/1676-2444.20150056 In 2009, the US Food and Drug Administration (FDA) approved the Clinical and Laboratory Standards Institute ([CLSI] – formerly NCCLS) consensus standard for auto verification of clinical laboratory test results(1). That guideline provides a general framework

JBPML puts its commitment to the care of safety in the laboratory Read More »

Comparison between immunofixation and electrophoresis for the early detection of relapsed multiple myeloma

Article Type, Issue, Laboratory Medicine, Vol 51, Issue 6 / wadmin

Marta Helena C. Aita; Luiz Claudio Arantes; Bruno C. Aita; José Edson P. SilvaJ. Bras. Patol. Med. Lab. 2015;51(6):359-368DOI: 10.5935/1676-2444.20150057 ABSTRACT INTRODUCTION: Multiple myeloma (MM) is an incurable progressive hematological neoplasia characterized by heterogeneous evolution and by relapses after therapy.OBJECTIVE: Compare the effectiveness of serum immunofixation (SIF) and electrophoresis (SPE) techniques in the detection of relapses in

Comparison between immunofixation and electrophoresis for the early detection of relapsed multiple myeloma Read More »

Comparison between immunofixation and electrophoresis for the early detection of relapsed multiple myeloma

Laboratory Medicine / wadmin

Comparação entre imunofixação e eletroforese na detecção precoce de recidivas do mieloma múltiplo Marta Helena C. Aita; Luiz Claudio Arantes; Bruno C. Aita; José Edson P. Silva Universidade Federal de Santa Maria (UFSM) DOI: 10.5935/1676-2444.20150057 Corresponding author Marta Helena Carlesso AitaEstrada Padre Gabriel Bolzan, 1.777, casa 71; São José, km 3CEP: 97095-500; Santa Maria-RS, Brazile-mail: marta.hc.aita@gmail.com

Comparison between immunofixation and electrophoresis for the early detection of relapsed multiple myeloma Read More »

Autoverification of the automated blood cell counter (CBC) in a reference laboratory in Bogota, Colombia

Laboratory Medicine / wadmin

Autoverificação do contador de células automatizado de sangue (CBC) em um laboratório de referência em Bogotá, Colômbia Oscar Martinez-Nieto1; Adriana Lozano-Gaitán1; Paola Beltrán-Diaz1; Ivan Leonardo Mojica-Figueroa1; Olga Lucia Morales-Reyes1; Mario A. Isaza-Ruget2 1. Clínica Colsanitas S.A., Bogotá, Colômbia2. Organización Sanitas S.A., Bogotá, Colômbia DOI: 10.5935/1676-2444.20150058 Corresponding author Oscar Martínez-NietoRua Carrera 69 C, 99-45Bogotá DC, Colombia;

Autoverification of the automated blood cell counter (CBC) in a reference laboratory in Bogota, Colombia Read More »

Autoverification of the automated blood cell counter (CBC) in a reference laboratory in Bogota, Colombia

Article Type, Issue, Laboratory Medicine, Vol 51, Issue 6 / wadmin

Oscar Martinez-Nieto; Adriana Lozano-Gaitán; Paola Beltrán-Diaz; Ivan Leonardo Mojica-Figueroa; Olga Lucia Morales-Reyes; Mario A. Isaza-RugetJ. Bras. Patol. Med. Lab. 2015;51(6):369-375DOI: 10.5935/1676-2444.20150058 ABSTRACT INTRODUCTION: The clinical laboratory is part of the group of actors in health systems that are under increasing pressure by users and administrators to increase their productivity in order to respond efficiently to the

Autoverification of the automated blood cell counter (CBC) in a reference laboratory in Bogota, Colombia Read More »

Cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer’s disease

Laboratory Medicine / wadmin

Aplicação de biomarcadores do fluido cerebrospinal no diagnóstico diferencial da doença de Alzheimer Carolina A. Magalhães1; Micheli Figueiró1; Vanessa G. Fraga1; Elvis C. Mateo2; André A. S. F. Toledo1; Maria das Graças Carvalho1; Paulo Caramelli1; Karina B. Gomes1 1. Universidade Federal de Minas Gerais (UFMG)2. Instituto Hermes Pardini DOI: 10.5935/1676-2444.20150059 Corresponding author Karina Braga GomesFaculdade

Cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer’s disease Read More »

Cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer’s disease

Article Type, Issue, Laboratory Medicine, Vol 51, Issue 6 / wadmin

Carolina A. Magalhães; Micheli Figueiró; Vanessa G. Fraga; Elvis C. Mateo; André A. S. F. Toledo; Maria das Graças Carvalho; Paulo Caramelli; Karina B. GomesJ. Bras. Patol. Med. Lab. 2015;51(6):376-382DOI: 10.5935/1676-2444.20150059 ABSTRACT INTRODUCTION: Several studies have been conducted in order to validate cerebrospinal fluid biomarkers for the diagnosis of Alzheimer’s disease (AD), aiming primarily to facilitate

Cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer’s disease Read More »